Search results
First trial over Zantac cancer claims set to begin in Chicago
Reuters via Yahoo News· 2 weeks ago(Reuters) -The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and...
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
Investor's Business Daily· 2 years agoPharmaceutical stocks GSK, Sanofi and Haleon have wiped out a combined $31 billion in market cap...
First it was blood pressure medication. Now FDA eyes more drugs for cancer-causing chemical.
USA TODAY via Yahoo News· 1 year agoFor people managing high blood pressure, recalls of the carcinogen-tainted drug quinapril might...
FTSE 100: GSK loses £4.5bn in value on Zantac lawsuit concerns
Yahoo Finance UK· 2 years agoGSK lost billions in value amid litigation concerns over the heartburn drug Zantac. Photo: Drew...
GSK's Relief For Few Months, First Trial Claiming Zantac Caused Cancer Pushed Into Late 2023
Benzinga via Yahoo Finance· 1 year agoThe first scheduled trial expected next week, related to GSK Plc's (NYSE: GSK) Zantac associated...
Fate of most remaining Zantac lawsuits weighed by Delaware judge
Reuters via AOL· 4 months ago(Reuters) -GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week...
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports
Reuters via Yahoo Finance· 2 days agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper...
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
Reuters via Yahoo Finance· 1 week agoThe agreements cover cases in U.S. state courts but don't completely resolve the company's exposure...
GSK attacks ‘meritless claims’ over heartburn drug Zantac
The Independent via Yahoo News· 2 years agoGSK and its consumer spin-off brand Haleon have hit back at market speculation over heartburn drug...
Plaintiff in first Zantac lawsuit set for trial drops case
Reuters via Yahoo Finance· 2 years agoThe plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial has...